Financial statements Medax
Cash inflows of MEDAX
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Net cash from operating expenses | -2 030 592,81 | 2 389 287,44 | 3 778 695,07 | 1 952 178,61 | -564 681,06 | 2 802 310,17 |
| Net cash flow from investing activities | 3 402 110,85 | 188 940,06 | 130 093,00 | 171 499,64 | 1 064 748,85 | -460 398,23 |
| Net cash flow from financial activities | -2 340 322,01 | -2 331 017,89 | -2 648 562,00 | -3 322 314,51 | -585 366,28 | -2 050 775,09 |
| Total net cash flow | -968 803,97 | 247 209,61 | 1 260 226,07 | -1 198 636,26 | -85 298,49 | 291 136,85 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.